Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec 14;192(50):E1834-E1835.
doi: 10.1503/cmaj.201764-f.

Intégration des essais randomisés dans les soins cliniques : comment le Canada peut faire mieux

[Article in French]
Srinivas Murthy  1 , Robert A Fowler  1 , Andreas Laupacis  1
Affiliations
Editorial

Intégration des essais randomisés dans les soins cliniques : comment le Canada peut faire mieux

[Article in French]
Srinivas Murthy et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Intérêts concurrents: Voir www.cmaj.ca/site/misc/cmaj_staff.xhtml pour Andreas Laupacis. Aucun autre intérêt concurrent déclaré.

References

    1. Horby P, Lim WS, Emberson J, et al. RECOVERY Collaborative Group. Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report. medRxiv 22 Juin 2020. 10.1101/2020.06.22.20137273. - DOI - PubMed
    1. RECOVERY Collaborative Group Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19 — preliminary report. New Engl J Med 17 Juillet 2020. [Cyberpublication avant impression]. 10.1056/NEJMoa2021436. - DOI - PubMed
    1. Nuffield Department of Population Health. No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19: Statement from the Chief Investigators of the Randomised Evaluation of COVid-19 thERapY (RECOVERY) Trial on hydroxychloroquine, 5 June 2020. Oxford (Royaume-Uni); RECOVERY – Randomised Evaluation of COVID-19 Therapy 2020. Accessible ici : www.recoverytrial.net/news/statement-from-the-chief-investigators-of-the... (consulté le 20 juillet 2020).
    1. Nuffield Department of Population Health. No clinical benefit from use of lopinavir-ritonavir in hospitalised COVID-19 patients studied in RECOVERY. Oxford (Royaume-Uni); RECOVERY – Randomised Evaluation of COVID-19 Therapy 2020. Accessible ici : www.recoverytrial.net/news/no-clinical-benefit-from-use-of-lopinavir-rit... (consulté le 20 juillet 2020).
    1. Kupferschmidt K. One U.K. trial is transforming COVID-19 treatment. Why haven’t others delivered more results? [En ligne]. Science 2 Juillet 2020.

Publication types